A Disclosure Statement for The Center for Health & Pharmaceutical Law & Policy
The Center for Health & Pharmaceutical Law & Policy of Seton Hall Law School is committed to independent academic inquiry focusing on health and pharmaceutical law and policy. As a part of Seton Hall University, the Newark-based Law School is a nonprofit 501(c)(3) organization. The University and Law School engage in fundraising from alumni and other contributors. Remaining committed to examining divergent perspectives on policy issues related to health and pharmaceutical law and policy, is critical to the mission of the Center.
Law School faculty members and Center Staff are devoted to academic independence in their research and transparency in their relationships. As such, funding sources are announced on all published materials and on the Law School Web site. Regardless of whether financial support is received in the form of an endowment, as unrestricted funds or for a specific project, Law School and Center donors are not involved in the academic work of Law School professors or Center Staff. Grants and donations are only accepted if they do not limit the faculty’s or the Center’s ability to carry out research free of outside influence and consistent with the Center’s mission and values.
Seton Hall Law School funds the salaries of the Executive Director and faculty affiliated with the Center for Health & Pharmaceutical Law & Policy. Research and administrative support for the Center are jointly funded by Seton Hall Law School and by unrestricted funds provided by pharmaceutical companies, with the Law School currently providing the majority of the funding.
The Center for Health & Pharmaceutical Law & Policy and its faculty assume sole responsibility for the content of its publications and position statements. The Center does not issue publications or statements on behalf of any donor or other entity.
The pharmaceutical companies that have provided funding to the Center or to the Law School are listed below.
- Bristol-Myers Squibb provided a $5 million endowment in 2005 in support of The Harvey Washington Wiley Chaired Professorship in Corporate Governance & Business Ethics. The Law School is recruiting candidates for this position.
- Johnson & Johnson provided $100,000 in 2009 as seed funding for two projects: (i) a program on "Strategies for Compliance Professionals: Honing Decision-Making Skills," and (ii) creation and implementation of an international compliance program. In 2008, Ortho-McNeil Janssen Scientific Affairs, a subsidiary of Johnson & Johnson, provided $49,900 in unrestricted funds. Johnson & Johnson provided $50,000 in 2007 and $100,000 in 2006 in unrestricted funds to support the Center. Two of Johnson & Johnson’s subsidiaries, Centocor, Inc., and Ortho Biotech, provided $125,000 in unrestricted funding to the Center in 2007.
- In 2006, sanofi-aventis provided $500,000 to Seton Hall Law School in "support and development of the Center for Health & Pharmaceutical Law and the programs and activities associated with the Center."
- In 2006, Schering-Plough Corporation made a $2.5 million commitment, to be paid over five years, to partially endow a tenured track/tenured faculty position dedicated to Health Care Regulation. The Law School will begin to recruit candidates for this position in the 2009-10 academic year.
- In 2008, Purdue Pharma provided $25,000 in unrestricted funding for the Center for Health & Pharmaceutical Law & Policy.
In 2008, Roche provided $50,000 for a symposium sponsored by the Gibbons Institute of Law, Science & Technology, the Seton Hall Law Review, and the Center on "Preparing for a Pharmaceutical Response to Pandemic Influenza."